Mycotoxin Testing Market by Type and Technology- Global Industry Analysis & Forecast to 2027

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Mycotoxin Testing  Market, By Type

5.1.     Introduction

5.2.     Global Mycotoxin Testing  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Mycotoxin Testing  Revenue and Revenue Share by Type (2017-2021)

5.3.     Aflatoxins

5.3.1.  Global Aflatoxins Revenue and Growth Rate (2017-2021)

5.4.     Ochratoxin

5.4.1.  Global Ochratoxin Revenue and Growth Rate (2017-2021)

5.5.     Fumonisins

5.5.1.  Global Fumonisins Revenue and Growth Rate (2017-2021)

5.6.     Zearalenone

5.6.1.  Global Zearalenone Revenue and Growth Rate (2017-2021)

5.7.     Deoxynivalenol

5.7.1.  Global Deoxynivalenol Revenue and Growth Rate (2017-2021)

5.8.     Trichothecenes

5.8.1.  Global Trichothecenes Revenue and Growth Rate (2017-2021)

5.9.     Patulin

5.9.1.  Global Patulin Revenue and Growth Rate (2017-2021)

6.       Mycotoxin Testing  Market, By Technology

6.1.     Introduction

6.2.     Global Mycotoxin Testing  Revenue and Market Share by Technology (2017-2021)

6.2.1.  Global Mycotoxin Testing  Revenue and Revenue Share by Technology (2017-2021)

6.3.     Chromatography- & spectroscopy-based

6.3.1.  Global Chromatography- & spectroscopy-based Revenue and Growth Rate (2017-2021)

6.4.     Immunoassay-based

6.4.1.  Global Immunoassay-based Revenue and Growth Rate (2017-2021)

7.       Mycotoxin Testing  Market, By Region

7.1.     Introduction

7.2.     Global Mycotoxin Testing  Revenue and Market Share by Regions

7.2.1.  Global Mycotoxin Testing  Revenue by Regions (2017-2021)

7.3.     North America Mycotoxin Testing  by Countries

7.3.1.  North America Mycotoxin Testing  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Mycotoxin Testing  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Mycotoxin Testing  by Countries

7.4.1.  Europe Mycotoxin Testing  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Mycotoxin Testing  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Mycotoxin Testing  by Countries

7.5.1.  Asia-Pacific Mycotoxin Testing  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Mycotoxin Testing  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Mycotoxin Testing  by Countries

7.6.1.  South America Mycotoxin Testing  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Mycotoxin Testing  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Mycotoxin Testing  by Countries

7.7.1.  Middle East and Africa Mycotoxin Testing  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Mycotoxin Testing  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     SGS (Switzerland)

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Bureau Veritas (France)

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Eurofins (Luxembourg)

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Intertek (UK)

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Mérieux NutriSciences (US)

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     ALS Limited (Australia)

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Neogen (US) AsureQuality (New Zealand)

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Charm Sciences (US),

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Premier Analytical Services (UK)

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Dairyland Laboratories (US)

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Mycotoxin Testing  Market Forecast (2022-2027)

9.1.     Global Mycotoxin Testing  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Mycotoxin Testing  Market Forecast by Regions (2022-2027)

9.2.1.  North America Mycotoxin Testing  Market Forecast (2022-2027)

9.2.1.1.  United States Mycotoxin Testing  Market Forecast (2022-2027)

9.2.1.2.  Canada Mycotoxin Testing  Market Forecast (2022-2027)

9.2.1.3.  Mexico Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.  Europe Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.1.  Germany Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.2.  France Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.3.  UK Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.4.  Russia Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.5.  Italy Mycotoxin Testing  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.1.  China Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.2.  Japan Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.3.  Korea Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.4.  India Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Mycotoxin Testing  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Mycotoxin Testing  Market Forecast (2022-2027)

9.2.4.  South America Mycotoxin Testing  Market Forecast (2022-2027)

9.2.4.1.  Brazil Mycotoxin Testing  Market Forecast (2022-2027)

9.2.4.2.  Argentina Mycotoxin Testing  Market Forecast (2022-2027)

9.2.4.3.  Columbia Mycotoxin Testing  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.3.  Egypt Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.5.  South Africa Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.6.  Turkey Mycotoxin Testing  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Mycotoxin Testing  Market Forecast (2022-2027)

9.3.     Mycotoxin Testing  Market Forecast by Type (2022-2027)

9.3.1.  Mycotoxin Testing  Forecast by Type (2022-2027)

9.3.2.  Mycotoxin Testing  Market Share Forecast by Type (2022-2027)

9.4.     Mycotoxin Testing  Market Forecast by Technology (2022-2027)

9.4.1.  Mycotoxin Testing  Forecast by Technology (2022-2027)

9.4.2.  Mycotoxin Testing  Market Share Forecast by Technology (2022-2027)

---

List of Tables

List of Tables and Figures:

Figure United States Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Mycotoxin Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Mycotoxin Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global Aflatoxins Revenue and Growth Rate (2017-2019)
Figure Global Ochratoxin Revenue and Growth Rate (2017-2019)
Figure Global Fumonisins Revenue and Growth Rate (2017-2019)
Figure Global Zearalenone Revenue and Growth Rate (2017-2019)
Figure Global Deoxynivalenol Revenue and Growth Rate (2017-2019)
Figure Global Trichothecenes Revenue and Growth Rate (2017-2019)
Figure Global Patulin Revenue and Growth Rate (2017-2019)
Table Global Mycotoxin Testing Revenue and Revenue Share by Technology (2017-2019)
Figure Global Chromatography- & spectroscopy-based Revenue and Growth Rate (2017-2019)
Figure Global Immunoassay-based Revenue and Growth Rate (2017-2019)
Table Global Mycotoxin Testing Revenue by Regions (2017-2019)
Figure North America Mycotoxin Testing Growth Rate (2017-2019)
Figure North America Mycotoxin Testing Revenue and Growth Rate (2017-2019)
Figure North America Mycotoxin Testing by Countries (2017-2019)
Figure North America Mycotoxin Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Mycotoxin Testing Growth Rate (2017-2019)
Figure United States Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Mycotoxin Testing Growth Rate (2017-2019)
Figure Canada Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Mycotoxin Testing Growth Rate (2017-2019)
Figure Mexico Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Mycotoxin Testing Growth Rate (2017-2019)
Figure Europe Mycotoxin Testing Revenue and Growth Rate (2017-2019)
Figure Europe Mycotoxin Testing by Countries (2017-2019)
Figure Europe Mycotoxin Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Mycotoxin Testing Growth Rate (2017-2019)
Figure Germany Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Mycotoxin Testing Growth Rate (2017-2019)
Figure France Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Mycotoxin Testing Growth Rate (2017-2019)
Figure UK Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Mycotoxin Testing Growth Rate (2017-2019)
Figure Russia Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Mycotoxin Testing Growth Rate (2017-2019)
Figure Italy Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Mycotoxin Testing Growth Rate (2017-2019)
Figure Rest of Europe Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Mycotoxin Testing Growth Rate (2017-2019)
Figure Asia-Pacific Mycotoxin Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Mycotoxin Testing by Countries (2017-2019)
Figure Asia-Pacific Mycotoxin Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Mycotoxin Testing Growth Rate (2017-2019)
Figure China Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Mycotoxin Testing Growth Rate (2017-2019)
Figure Japan Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Mycotoxin Testing Growth Rate (2017-2019)
Figure Korea Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Mycotoxin Testing Growth Rate (2017-2019)
Figure India Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Mycotoxin Testing Growth Rate (2017-2019)
Figure Southeast Asia Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Mycotoxin Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Mycotoxin Testing Growth Rate (2017-2019)
Figure South America Mycotoxin Testing Revenue and Growth Rate (2017-2019)
Figure South America Mycotoxin Testing by Countries (2017-2019)
Figure South America Mycotoxin Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Mycotoxin Testing Growth Rate (2017-2019)
Figure Brazil Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Mycotoxin Testing Growth Rate (2017-2019)
Figure Argentina Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Mycotoxin Testing Growth Rate (2017-2019)
Figure Columbia Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Mycotoxin Testing Growth Rate (2017-2019)
Figure Rest of South America Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Mycotoxin Testing Growth Rate (2017-2019)
Figure Middle East and Africa Mycotoxin Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Mycotoxin Testing by Countries (2017-2019)
Figure Middle East and Africa Mycotoxin Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Mycotoxin Testing Growth Rate (2017-2019)
Figure Saudi Arabia Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Mycotoxin Testing Growth Rate (2017-2019)
Figure United Arab Emirates Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Mycotoxin Testing Growth Rate (2017-2019)
Figure Egypt Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Mycotoxin Testing Growth Rate (2017-2019)
Figure Nigeria Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Mycotoxin Testing Growth Rate (2017-2019)
Figure South Africa Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Mycotoxin Testing Growth Rate (2017-2019)
Figure Turkey Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Mycotoxin Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table SGS (Switzerland) Mycotoxin Testing Financial Overview
Table Bureau Veritas (France) Mycotoxin Testing Financial Overview
Table Eurofins (Luxembourg) Mycotoxin Testing Financial Overview
Table Intertek (UK) Mycotoxin Testing Financial Overview
Table Mérieux NutriSciences (US) Mycotoxin Testing Financial Overview
Table ALS Limited (Australia) Mycotoxin Testing Financial Overview
Table Neogen (US) AsureQuality (New Zealand) Mycotoxin Testing Financial Overview
Table Charm Sciences (US), Mycotoxin Testing Financial Overview
Table Premier Analytical Services (UK) Mycotoxin Testing Financial Overview
Table Dairyland Laboratories (US) Mycotoxin Testing Financial Overview
Figure Global Mycotoxin Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Mycotoxin Testing Market Forecast by Regions (2019-2027)
Figure North America Mycotoxin Testing Market Forecast (2019-2027)
Figure United States Mycotoxin Testing Market Forecast (2019-2027)
Figure Canada Mycotoxin Testing Market Forecast (2019-2027)
Figure Mexico Mycotoxin Testing Market Forecast (2019-2027)
Figure Europe Mycotoxin Testing Market Forecast (2019-2027)
Figure Germany Mycotoxin Testing Market Forecast (2019-2027)
Figure France Mycotoxin Testing Market Forecast (2019-2027)
Figure UK Mycotoxin Testing Market Forecast (2019-2027)
Figure Russia Mycotoxin Testing Market Forecast (2019-2027)
Figure Italy Mycotoxin Testing Market Forecast (2019-2027)
Figure Rest of Europe Mycotoxin Testing Market Forecast (2019-2027)
Figure Asia-Pacific Mycotoxin Testing Market Forecast (2019-2027)
Figure China Mycotoxin Testing Market Forecast (2019-2027)
Figure Japan Mycotoxin Testing Market Forecast (2019-2027)
Figure Korea Mycotoxin Testing Market Forecast (2019-2027)
Figure India Mycotoxin Testing Market Forecast (2019-2027)
Figure Southeast Asia Mycotoxin Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Mycotoxin Testing Market Forecast (2019-2027)
Figure South America Mycotoxin Testing Market Forecast (2019-2027)
Figure Brazil Mycotoxin Testing Market Forecast (2019-2027)
Figure Argentina Mycotoxin Testing Market Forecast (2019-2027)
Figure Columbia Mycotoxin Testing Market Forecast (2019-2027)
Figure Rest of South America Mycotoxin Testing Market Forecast (2019-2027)
Figure Middle East and Africa Mycotoxin Testing Market Forecast (2019-2027)
Figure Saudi Arabia Mycotoxin Testing Market Forecast (2019-2027)
Figure United Arab Emirates Mycotoxin Testing Market Forecast (2019-2027)
Figure Egypt Mycotoxin Testing Market Forecast (2019-2027)
Figure Nigeria Mycotoxin Testing Market Forecast (2019-2027)
Figure South Africa Mycotoxin Testing Market Forecast (2019-2027)
Figure Turkey Mycotoxin Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Mycotoxin Testing Market Forecast (2019-2027)
Figure Global Mycotoxin Testing Forecast by Type (2019-2027)
Figure Global Mycotoxin Testing Market Share Forecast by Type (2019-2027)
Figure Global Mycotoxin Testing Forecast by Type (2019-2027)
Figure Global Mycotoxin Testing Forecast by Technology (2019-2027)
Figure Global Mycotoxin Testing Market Share Forecast by Technology (2019-2027)
Figure Global Mycotoxin Testing Forecast by Technology (2019-2027)

Please Note: Data related to the Companies are subject to Availability.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country